HC Wainwright & Co. Maintains Buy on Verastem, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Sean Lee maintains a Buy rating on Verastem (NASDAQ:VSTM) but lowers the price target from $17.5 to $7.
August 12, 2024 | 5:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HC Wainwright & Co. analyst Sean Lee maintains a Buy rating on Verastem but lowers the price target from $17.5 to $7.
The lowered price target from $17.5 to $7 suggests a significant reduction in expected future performance, which could negatively impact investor sentiment in the short term despite the maintained Buy rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100